Please assess the completion status of the following clinical trial:

Trial Title: Benefit and Tolerability of a Probiotic Product in Infants With Abdominal Discomfort

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female singleton~* ≥ 2 weeks and ≤ 12 weeks of age~* Exclusively breastfed at screening~* Abdominal discomfort (infant colic) in the week prior to enrollment, according to the statement of the parent(s) and/or guardian(s)~* Episodes of fussy crying that lasted at least 3 hours a day for at least 3 days in the 7 days prior to enrollment, according to the statement of the parent(s) and/or guardian(s)~* Voluntary, written informed consent of the parent(s) and/or guardian(s) to participate in the study~* Born at full term (37-42 after last menstruation period)~* Birth weight: 2500 - 4500 g~* Weight-for-age ≥ 3th and ≤ 97th percentile according to WHO growth tables / charts~* Apparently healthy at birth (Apgar ≥ 8) and at screening visit~* No major complications during pregnancy or at birth~* Mother 19-45 years of age at childbirth~* Ability of parent(s) and/or guardian(s) to attend visits, interviews and willingness to fill out questionnaires~Exclusion Criteria:~* Intolerance to investigational product/its ingredients~* Severe medical condition or illness, congenital abnormality~* Gastrointestinal disorders (e.g. reflux esophagitis)~* Intake of probiotics and/or antibiotics in the week preceding recruitment and during the study~* Formula feeding at screening/randomisation~* Allergy or atopic disease (family history)~* Participation in another study~* Mother's health condition that may interfere with her ability to take care of her infant~* Mother affected by hepatitis B, HIV or Guillain-Barré Syndrome~* Use of antibiotics by the mother in the week

- Gender: ALL
- Minimum Age: 2 Weeks
- Maximum Age: 12 Weeks
- Healthy Volunteers: None

Study Arms:
- Probiotics (Type: ACTIVE_COMPARATOR): None
- Control (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).